Here are relevant reports on : speech-therapy-market
-
Antibody Therapeutics Market by Product (Commercial, Pipeline), Format (mAb, ADC, Fragment), Target (PDL1, Cytokine), Therapy area (Oncology, Neurology, Inflammatory), Source (Human, Humanized), ROA (IV, SC), Region, Competition - Global Forecast to 2035
The global antibody therapeutics market is projected to reach USD 597.1 billion by 2035, growing at a CAGR of 7.5% during the forecast period (2026–2035). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: July 2026
- Price: $ 4950
- TOC Available:
-
Elastomeric Pumps Market by Product (Continuous Rate, Variable Rate), Treatment (Chemotherapy, Antibiotic, Iron Chelation Therapy), Administration Route (Intravenous, Subcutaneous), End User (Hospital, Ambulatory Surgery Center) - Global Forecast to 2022
The global elastomeric pumps market is expected to reach USD 592.0 Million by 2022 from USD 432.1 Million in 2017, growing at a CAGR of 6.5% from 2017 to 2022. Increasing number of surgeries, wide usage in treatment, rising incidence of chronic diseases, and increasing adoption for disposable infusion pumps, are some of the major driving factors driving the growth of the global elastomeric pumps market. However, the high cost of treatment and challenges in reimbursement are hindering the growth of this market to a certain extent.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Healthcare Market Outlook – [By Health Indicators (Life Expectancy, Mortality), Disease Burden (Epidemiology, Average Cost Of Therapy), Health System (Infrastructure, Expenditure), Regulatory Landscape] - Analysis & Forecast To 2020
The APAC region showcases diverse healthcare challenges across various countries. These range from improving healthcare access in developing countries of Vietnam to tackling rising diabetes, cancer, and cardiovascular diseases in well developed nations of Japan and Pacific countries. In addition, regions of China and India that lie in between developing and well developed countries are facing increase in diseases burden, problems of poverty, limited access to high quality treatment, and slow increase in disposable income. The APAC Healthcare Market Outlook examines the health indicators and healthcare system across India, China, Japan, Singapore, Indonesia, Thailand, Malaysia, Vietnam, Australia, and New Zealand. The APAC Healthcare Market Outlook is segmented into five broad categories: health status, healthcare system assessment, healthcare regulatory landscape, medical devices infrastructure assessment, hospital chain assessment in top 10 hospitals.
- Published: October 2026
- Price: $ 4950
- TOC Available:
-
Vitamin D Therapy Market by Route of administration (Oral, Parenteral), Age Group (Children, Adult, Senior Adult), Purchase Pattern (OTC, Prescription), Application (Osteoporosis, Rickets, Autoimmune Disorder, Skin Diseases) - Global Forecast to 2024
The vitamin D therapy market is projected to reach USD 3.3 billion by 2024 from USD 1.9 billion in 2019, at a CAGR of 11.6% during the forecast period. Growth in this market is largely driven by the growing awareness about vitamin D deficiency and the presence of a large target patient population. On the other hand, the fortification of foods is likely to challenge the growth of this market. Some of the major players in this market include Abbott (US), Sanofi (France), GlaxoSmithKline plc (UK), Pfizer Inc. (US), Merck & Co., Inc. (US), Torrent Pharmaceuticals Ltd. (India), Novartis International AG (Switzerland), Alkem Laboratories (India), Sun Pharmaceutical Industries Ltd. (India), and Cadila Healthcare Ltd. (India).
- Published: April 2019
- Price: $ 4950
- TOC Available:
-
Europe Patient Engagement Solutions Market by Therapy (Chronic [CVD, Obesity], Women's Health), Functionality (Telehealth, E-Prescribing, Scheduling, Billing, Education), End User (Hospitals, ASCs, Payers, Patients) - Forecast to 2030
The Europe Patient Engagement Solutions market, valued at USD 6.42 billion in 2024, stood at USD 7.35 billion in 2025 and is projected to advance at a resilient CAGR of 12.7% from 2025 to 2030, culminating in a forecasted valuation of USD 13.37 billion by the end of the period. This development is fueled by the changing trend toward value-based and outcome-oriented care, escalating the need to provide continuous interaction with patients outside of clinical care, and an increasing use of digital front-door solutions (patient portals and virtual assistants).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Leukapheresis Market by Type (Filter, Membrane Separator, Centrifugal Device), Leukopak (Mobilized, Isolated PBMC), Application (Research [Cell & Gene Therapy, Transplantation], Therapeutic), Indication, End User, Region - Global Forecast to 2031
The global Leukapheresis market, valued at USD 83.3 billion in 2025, stood at USD 90.6 billion in 2026 and is projected to advance at a resilient CAGR of 8.9% from 2026 to 2031, culminating in a forecasted valuation of USD 138.7 billion by the end of the period. This growth is driven by the increasing number of therapeutic and manufacturing applications for leukapheresis in hematologic disorders, as well as the rising demand for high-quality starting materials used in cell and gene therapy, including CAR-T, TCR, and NK-cell programs.
- Published: June 2026
- Price: $ 4950
- TOC Available:
-
Transdermal Pharmaceutical Packaging Market by Type (Patches, Gels), Material (Plastic, Glass, Metal), Application (Chronic Disease Management, Pain Management, Hormone Replacement Therapy), and Region – Global Forecast to 2030
The transdermal pharmaceutical packaging market is projected to grow from USD 4.05 billion in 2025 to USD 8.13 billion by 2030, at a CAGR of 15.0%. The key players in the transdermal pharma packaging market include 3M Company (US), Hisamitsu Pharmaceutical (Japan), Novartis (Switzerland), Teva Pharmaceutical Industries (Israel), Johnson & Johnson (US), Bayer (Germany), GlaxoSmithKline (UK), LTS Lohmann Therapie-Systeme (Germany), Noven Pharmaceuticals (US), and Nitto Denko (Japan).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Cryovials Market by Material (Polypropylene, Polyethylene, Glass), Application (Biobanking, Clinical Diagnostics, Cell & Gene Therapy, Drug Discovery), End User (Hospitals, Academia, Pharma-biopharma Cos., Biobanks) - Global Forecast to 2031
The global cryovials market is projected to reach USD 0.31 billion by 2031, growing at a CAGR of 5.5% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
CAR T-Cell Therapy Market by Product (Abecma, Breyanzi, Carvykti, Yescarta, Tecartus, Kymriah), Target (CD19, BCMA), Indication (Multiple Myeloma, Leukemia, Lymphoma), Demographic (Adult, Pediatric), Region, Competitive Landscape - Global Forecast to 2031
The global CAR T-cell therapy market, valued at USD 5.98 billion in 2025, stood at USD 6.78 billion in 2026 and is projected to advance at a resilient CAGR of 14.9% from 2026 to 2031, culminating in a forecasted valuation of USD 13.56 billion by the end of the period. The global CAR T-cell therapy market is growing due to rapid technological advances alongside rising investments from large pharma and well-funded biotech's.
- Published: February 2026
- Price: $ 4950
- TOC Available:
-
CAR-t Cells Therapy Market by Type, End-Use Industry, Application and Region – Global Forecast to 2030
CAR-t Cells Therapy Market
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 41 to 50 of 50
